Get started
ENVVENO MEDICAL DL-,00001ENVVENO MEDICAL DL-,00001ENVVENO MEDICAL DL-,00001

ENVVENO MEDICAL DL-,00001

No trades
See on Supercharts
Overview
Financials News Ideas Minds

5HJ chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪64.28 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.62EUR
Net income (FY)
‪−21.31 M‬EUR
Revenue (FY)
—
Shares float
‪13.28 M‬
Beta (1Y)
0.30

About enVVeno Medical Corporation

Sector
Health Technology
Industry
Medical Specialties
CEO
Robert Andrew Berman
Website
hancockjaffe.com
Headquarters
Irvine
Employees (FY)
31
Founded
1999
FIGI
BBG00NNNW418
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ENVVENO MEDICAL DL-,00001 stocks are traded under the ticker 5HJ.
5HJ reached its all-time high on Aug 21, 2020 with the price of 15.62 EUR, and its all-time low was 2.40 EUR and was reached on Jun 8, 2023. View more price dynamics on 5HJ chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ENVVENO MEDICAL DL-,00001 financials in yearly and quarterly reports right on TradingView.
ENVVENO MEDICAL DL-,00001 is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
5HJ earnings for the last quarter are −0.29 EUR per share, whereas the estimation was −0.37 EUR resulting in a 22.50% surprise. The estimated earnings for the next quarter are −0.34 EUR per share. See more details about ENVVENO MEDICAL DL-,00001 earnings.
ENVVENO MEDICAL DL-,00001 revenue for the last quarter amounts to 0 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
5HJ net income for the last quarter is ‪−4.63 M‬ EUR, while the quarter before that showed ‪−5.12 M‬ EUR of net income which accounts for 9.60% change. Track more ENVVENO MEDICAL DL-,00001 financial stats to get the full picture.
No, 5HJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 27, 2024, the company has 31.00 employees. See our rating of the largest employees — is ENVVENO MEDICAL DL-,00001 on this list?
Like other stocks, 5HJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENVVENO MEDICAL DL-,00001 stock right from TradingView charts — choose your broker and connect to your account.